The vaccines from Johnson & Johnson and Verocel are being studied by the National Institute of Health (INS) for possible combined administration. The first targets of the clinical trials will be 360 unvaccinated people between 18 and 65 years old in the capital of Mozambique, Maputo. The idea of the combined use of these vaccines aims...
Post
Covid-19. WHO calls for more studies on effectiveness of omicron vaccines
The World Health Organization (WHO) today called for further research to ascertain the effectiveness of existing vaccines in combating the omicron variant of covid-19, even though other vaccines are already in development. The latest technical brief from the world health agency aims to answer some of the outstanding questions about...
Post
Covid-19 may become "eternal" in Africa, like tuberculosis and HIV/AIDS
The African continent needs to vaccinate more than half of its total population, or 70% of the inhabitants, against covid-19, and otherwise this disease could become endemic in Africa like tuberculosis and HIV/AIDS. The warning comes from the Director of the African Union Center for Disease Control and Prevention (Africa CDC),...
Post
AstraZeneca donates 2.8 million doses to Mozambique
The pharmaceutical group AstraZeneca offered about 2.8 million doses of AstraZeneca's Covid-19 vaccine to Mozambique through Covax. Therefore, the country will have a total of 4.9 million doses of AstraZeneca's Covid-19 vaccine during the year 2021. On the occasion, the Minister of Health, Armindo...
Post
Covid-19: Omicron dodges vaccines better than delta
The omicron variant of covid-19 circumvents immunity in vaccinated people better than delta, according to the conclusion of a Danish study published late last year, and this finding opens a window to explain why the new strain is easier to spread. The researchers at the University of Copenhagen, Statistics...
Post
Covid-19. INS launches clinical trial today to evaluate combined use of two vaccines
The National Institute of Health (INS) is launching, today, Monday, the Phase 2 clinical trial ECOVA-02 in Mozambique, in order to evaluate the combined use of two different vaccines against covid-19, in adults. This is a study that will evaluate the safety and immunogenicity of a two-dose regimen using the...
Post
Omicron resists three doses of one of the most widely used vaccines in the world. It is from China
A laboratory study has confirmed the ineffectiveness of two doses and one more booster of the Chinese-made covid-19 vaccine, and one of the most widely used in the world. The research found that the three doses of the vaccine from Sinovac Biotech Ltd. did not produce sufficient levels of neutralizing antibodies to protect against the omicron variant. The work...
Post
Omicron. Unvaccinated pregnant women are more vulnerable to infection
The risk of severe covid-19 is particularly acute in the third trimester and raises the prospect of prematurity and stillbirth. It also raises the possibility of long-term health problems. Early clinical trials of covid-19 vaccines excluded a large number of pregnant women, but also, they themselves stayed away from the trials because they were...
Post
"No country will get out of pandemic with vaccination booster," warns WHO
"No country will emerge from the covid-19 pandemic with booster doses of vaccines," warned this Wednesday, the director-general of the World Health Organization (WHO), who has spoken out against administering additional doses when a portion of the world's population, the poorest, particularly in Africa, remain unimmunized. According to Tedros Adhanom Ghebreyesus, who...
Post
Covid-19. There is a country that is already giving the fourth dose of vaccines - "a second booster"
The first country to suggest and introduce the administration of the third dose or booster dose against covid-19 is now back on the front lines as it prepares to give the fourth dose to prevent the disease. The Government of Israel has announced that it will move towards administering the third dose of vaccines, in a...